| 证券代码 | GHDX.O |
| 证券名称 | Genomic Health Inc |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | 主板 |
| 发行方式 | 公开发售 |
| 首发上市日 | 2005-09-29 |
| 首发价格(元) | 12 USD |
| 首发数量(股) | 5016722 |
| 首发募资额(元) | 60,200,664.00 USD |
| 首发主承销商 | J.P. Morgan Securities Inc.,Lehman Brothers Inc |
| 货币单位 | USD |
| 公司名称 | Genomic Health, Inc. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 301 Penobscot Drive, Redwood City, California, USA |
| 成立日期 | 2000-08-22 |
| 董事会主席 | - |
| 公司属地 | United States 美国 |
| 公司网址 | www.genomichealth.com |
| 电话 | +1 (650) 556-9300 |
| 传真 | +1 (650) 556-1132 |
| 公司简介 | Genomic Health, Inc. is a global healthcare company that provides actionable genomic information to personalize cancer treatment decisions. The Company develops and globally commercializes genomic-based clinical laboratory services that analyze the underlying biology of cancer, allowing physicians and patients to make individualized treatment decisions. |